![]() |
市场调查报告书
商品编码
1433393
2023-2030 年全球 NGS 样品製备市场Global NGS Sample Preparation Market 2023-2030 |
预计在预测期内(2023-2030年),全球NGS样本製备市场将以14.7%的CAGR显着增长。市场的成长归因于定序成本下降导致对基因组定序的高需求。不断努力最大限度地降低测序总成本有助于 NGS 样品製备市场的成长。简化样本库製备方法有助于显着降低成本。例如,2023 年 11 月,New England Biolabs (NEB) 发布了 NEBNextUltraExpress DNA 和 RNA 文库製备试剂盒,用于 Illumina 平台上的下一代定序。新试剂盒提供了更快、更简单的工作流程来产生高品质的文库,允许在一天或两小时内完成 RNA 和 DNA 文库的製备,并具有自动化友好的工作流程和最小化的耗材浪费。然而,低成本替代品的容易取得可能会限制市场的成长。
全球 NGS 样品製备市场按产品类别、应用和最终用户进行细分。根据产品类别,市场细分为试剂和消耗品以及工作站。根据应用,市场细分为诊断、药物发现等。此外,根据最终用户,市场细分为医院和诊所、学术和研究机构、製药和生物技术公司等。诊断子类别预计将占据产品类别领域的很大一部分市场份额。这是由于对基于NGS的临床诊断的需求不断增长以及包括癌症在内的遗传疾病的盛行率不断增加。
在这个产品类别中,工作站细分市场预计将在全球 NGS 样品製备市场中占据相当大的份额。该细分市场的成长归因于实验室自动化需求的增加。实验室正在迅速采用自动化解决方案,以处理不断增加的样品量、提高效率并减少动手时间。 Fontus 工作站透过提供自动化液体处理解决方案来满足需求。例如,2023 年7 月,Revvity 推出了Fontus 自动液体处理工作站,这是一款下一代液体处理程序,融合了公司先前平台的最先进技术,旨在提供更简单、更快速的工作流程,为下一代定序(NGS)提供更好的结果)和诊断研究应用。
全球NGS样本製备市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,预计亚太地区在预测期内将呈现最快的CAGR。中国和印度等发展中国家越来越多地使用NGS技术,以及各个领域对基于NGS的研究的需求不断增加,这是促进区域市场成长的关键因素。
北美在全球 NGS 样品製备市场中占有相当大的份额
Global NGS Sample Preparation Market Size, Share &Trends Analysis Report by Product Class(Reagent and Consumables, and Workstations), by Application (Diagnostics, Drug Discovery, and Others)and by End-User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others), Forecast Period (2023-2030)
The global NGS sample preparation market is anticipated to grow at a significant CAGR of 14.7% during the forecast period (2023-2030).The market's growth is attributed to the high demand for genome sequencing due to decreasing sequencing costs. Continuous efforts to minimize the overall cost of sequencing have aided in the growth of the NGS Sample Preparation Market. Streamlining library preparation methods helps to considerably reduce costs. For instance, in November 2023, New England Biolabs (NEB) released the NEBNextUltraExpress DNA and RNA Library Prep Kits for next generation sequencing on the Illumina platform. New kits offer a faster, easier workflow for generating high-quality libraries, allowing RNA and DNA library prep in a single day or two hours, with automation-friendly workflows and minimal consumable waste. However, the easy availability of low cost alternative may restrain the market growth.
The global NGS sample preparation market is segmented on the product class, application and end-user. Based on the product class, the market is sub-segmented into reagent and consumables, and workstations. Based on the application, the market is sub-segmented into diagnostics, drug discovery, and others. Furthermore, on the basis of end-user, the market is sub-segmented into hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, and others. The diagnostics subcategory is expected to capture a significant portion of the market share within the product class segment. This is attributed to the growing demand for NGS-based clinical diagnostics and the increasing prevalence of genetic diseases including cancer.
Among the product class, the workstations sub-segment is expected to hold a considerable share of the global NGS Sample Preparation market. The segmental growth is attributed to the increased demand for automation in laboratories. Laboratories are rapidly adopting automated solutions in order to handle the increasing volume of samples, improve efficiency, and reduce hands-on time. Fontus workstations satisfy the demand by providing automated liquid handling solutions. For instance, in July 2023, Revvity launched the Fontus Automated Liquid Handling Workstation, a next-generation liquid handler that incorporates the greatest technology from company's previous platforms and is designed to provide easier and faster workflows that provide better results for next generation sequencing(NGS) and diagnostic research applications.
The global NGS sample preparation market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to exhibit fastest CAGR during the forecast period. The rising use of NGS technology in developing countries such as China and India, in addition to increasing demand for NGS-based research in a variety of fields are key factors contributing to the regional market growth.
The North America Holds Considerable Share in the Global NGS Sample Preparation Market
Among all regions, the North America holds considerable share in the global market. Regional growth is attributed to the sample standardization challenges. Sample variability due to varied origins is a challenges for standardization. It is essential to develop robust protocols that account for varied sample properties in order to achieve accurate pooling and subsequent read separation. According to the BMC Genomics, in August 2022,DNA and RNA sequencing is a widely used procedure for identifying diseases, understanding cell regulation, and understanding cell replication dynamics. Despite significant price reductions in the last decade, the final library sequencing only covers 20% of the total costs of a 10 million read sequencing project.
Automation could be an option for future cost reduction, but samples are not standardized due to their different origins. An approach to pool samples of different organisms and separate DNA/RNA reads bioinformatically after pooled sample preparation and sequencing could reduce total costs for DNA and RNA sequencing to 50%. This study investigates the limits of sample pooling for high-quality genomics and transcriptomics applications, considering error rates and evolutionary distances.
The major companies serving the NGS sample preparation market includes Bio-Rad Laboratories, Inc., Danaher Corp, DNASTAR, Huawei Technologies Co. Ltd, and Illumina, Inc. among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, QIAGEN acquired of Verogen, strengthening leadership\ in Human ID / the use of next-generation sequencing (NGS) technologies to drive the future of human identification (HID) and forensic investigation. It offers DNA collection, preparation kits, genetic testing analysis, and workflow automation products for forensic science laboratories and criminal investigators globally.